Form 4 for CVS CVS Health
Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-11 · accession 0001127602-22-014413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-13 | 2022-05-11 | CVS | Finucane Anne A. | Dir | A - Grant | $97.99 | +1,384 | 5,892 | +31% | +$135.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-11 | A | A | 1,384 | $97.99 | 5,892.25 | D | — | — | (F1) Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. |